Webinar swissmedic
Philippe Girard, Vice Director of Swissmedic will present Swissmedic Innovation Office and inform about the key points of the risk-based approach in terms of ATMP (Advanced Therapy Medicinal Products, like cell and gene therapies, Oligonucleotide products, tissue engineered products, organoide).
-
The webinar will be followed by a series of on-site meetings in Zurich to enable early dialogue between the regulator and the companies to identify scientific, legal and regulatory challenges early on. The on-site meetings will be open to all spin-offs and SMEs working on the topic of ATMP and take place at Wyss Zurich (Moussonstrasse 13, 8044 Zurich).
-
Registration
